STATISTICAL ANALYSIS TO COMPARE VARIOUS IN VITRO CRITERIA FOR PREDICTING ORGANIC ANION TRANSPORTING POLYPEPTIDES 1B1 (OATP1B1)-MEDIATED DRUG INTERACTIONS IN VIVO

被引:0
|
作者
Arya, V. [1 ]
Vaidyanathan, J. [1 ]
Yoshida, K. [2 ]
Yang, X. [1 ]
Zhang, L. [1 ]
机构
[1] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[2] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PI-008
引用
收藏
页码:S21 / S22
页数:2
相关论文
共 50 条
  • [31] Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
    Noe, Johannes
    Portmann, Renee
    Brun, Marie-Elise
    Funk, Christoph
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (08) : 1308 - 1314
  • [32] Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
    Maeda, Kazuya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (02) : 155 - 168
  • [33] Rapid and indirect inhibition of organic anion transporting polypeptide (OATP) 1B1 transport activity by lysosomotropic drug chloroquine: implications in OATP-mediated drug-drug interactions
    Alam, Khondoker
    Abuznait, Alaa
    Pahwa, Sonia
    Wang, Xueying
    Zhang, Pengyue
    Ding, Kai
    Li, Lang
    Yue, Wei
    DRUG METABOLISM REVIEWS, 2016, 48 : 152 - 152
  • [34] IDENTIFICATION AND EVALUATION OF CLINICAL SUBSTRATES OF ORGANIC ANION TRANSPORTING POLYPEPTIDES 1B1 AND 1B3
    McFeely, Savannah J.
    Ritchie, Tasha K.
    Yu, Jingjing
    Berglund, Eva Gil
    Nordmark, Anna
    Ragueneau-Majlessi, Isabelle
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S19 - S19
  • [35] Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3
    McFeely, Savannah J.
    Ritchie, Tasha K.
    Yu, Jingjing
    Nordmark, Anna
    Levy, Rene H.
    Ragueneau-Majlessi, Isabelle
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (04): : 379 - 387
  • [36] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
  • [37] Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment
    Wu, Lan-Xiang
    Guo, Cheng-Xian
    Chen, Wang-Qing
    Yu, Jing
    Qu, Qiang
    Chen, Yao
    Tan, Zhi-Rong
    Wang, Guo
    Fan, Lan
    Li, Qing
    Zhang, Wei
    Zhou, Hong-Hao
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (05) : 750 - 757
  • [38] Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia
    Campbell, SD
    de Morais, SM
    Xu, JHJ
    CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (02) : 179 - 187
  • [39] Cryo-EM structures of human organic anion transporting polypeptide OATP1B1
    Ziyang Shan
    Xuemei Yang
    Huihui Liu
    Yafei Yuan
    Yuan Xiao
    Jing Nan
    Wei Zhang
    Wenqi Song
    Jufang Wang
    Feiwen Wei
    Yanqing Zhang
    Cell Research, 2023, 33 : 940 - 951
  • [40] Cryo-EM structures of human organic anion transporting polypeptide OATP1B1
    Shan, Ziyang
    Yang, Xuemei
    Liu, Huihui
    Yuan, Yafei
    Xiao, Yuan
    Nan, Jing
    Zhang, Wei
    Song, Wenqi
    Wang, Jufang
    Wei, Feiwen
    Zhang, Yanqing
    CELL RESEARCH, 2023, 33 (12) : 940 - 951